$DFTX
Definium Therapeutics, Inc.
Nasdaq · Healthcare · Medicinal Chemicals & Botanical Products · New York, NY
DFTX chart
What traders are saying about $DFTX
Latest postsDefinium Therapeutics, Inc. news
- Definium Therapeutics Announces Planned Third-Quarter Results Webcast
TipRanks ·
- Definium Therapeutics Announces Inducement Grants to Ten New Employees
TipRanks ·
- Earnings call transcript: Definium Therapeutics jumps on q3 2026 trial wins
Investing.com Canada ·
- Definium Therapeutics Q3 2026 Earnings Call Transcript
Benzinga ·
- Why is Definium Therapeutics stock gaining today?
Investing.com ·
- Earnings Flash (DFTX) Definium Therapeutics Posts Q3 Per-Share Loss $0.46, vs. FactSet Est of $0.56 Loss
marketscreener.com ·
- Definium Therapeutics Q3FY26 Results: Net loss narrows to $51.0 million
scanx.trade ·
- Definium Therapeutics (DFTX) Misses Q3 EPS by 46c
StreetInsider ·
- Definium Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights
Yahoo Finance ·
- Definium Therapeutics (DFTX) Grants Stock Options to New Hires A
GuruFocus ·
- Definium Therapeutics Announces New Employee Inducement Grants
Yahoo Finance ·
- Definium Therapeutics (DFTX) Set to Report Q3 Earnings Amid Mixed Analyst Estimates
GuruFocus ·
Definium Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$183.8M | -$108.7M | -$95.7M | -$56.8M |
| Diluted EPS | $-2.06 | $-1.54 | $-2.44 | $-1.84 |
| Total assets (year end) | $440.1M | $302.2M | $124.5M | $170.0M |
| Cash and equivalents (year end) | $257.8M | $273.7M | $99.7M | $142.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Definium Therapeutics, Inc.
- Ticker
- DFTX (Nasdaq)
- Industry
- Medicinal Chemicals & Botanical Products
- Headquarters
- New York, NY
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- December 31
- SEC CIK
- 1813814
- Former names
- Mind Medicine (MindMed) Inc.
Frequently asked questions
What exchange is Definium Therapeutics, Inc. listed on?
Definium Therapeutics, Inc. trades on the Nasdaq under the ticker symbol DFTX.
What industry is Definium Therapeutics, Inc. in?
Definium Therapeutics, Inc. is classified by the SEC under "Medicinal Chemicals & Botanical Products", part of the Healthcare sector on StockTweeting.
Where is Definium Therapeutics, Inc. headquartered?
Definium Therapeutics, Inc.'s business address on file with the SEC is in New York, NY.
When does Definium Therapeutics, Inc.'s fiscal year end?
Definium Therapeutics, Inc.'s fiscal year ends on December 31.